Hims & Hers is a multi-billion-dollar company. They ran a Super Bowl ad. Their app is genuinely excellent. And we still don't recommend them for GLP-1 weight loss, for one narrow, arithmetic reason that has nothing to do with the quality of the service.
- Your bill is two separate charges: a membership and the medication. They're billed separately, they renew separately, and the advertised price only covers one of them.
- The membership is $39 for month one, then $149 every month after, so a $199 Wegovy pen is a $243 first month and $353 every month after that.
- Across the eight-to-twelve months GLP-1 therapy actually takes, that's about $4,100 for the year, not $199 a month.
- No multi-month lock-in on the standard plan, but cancel 48 hours before renewal, and cancelling the medication does not cancel the membership.
- Since March 2026 you get real brand-name Wegovy and Zepbound, not compounded copies. That part is a genuine upgrade.
- With insurance, all of this is moot: some people pay $0–$25 through the Novo savings card, and Medicare Part D now covers GLP-1 at $50/month.
Start with what they get right
Ignoring this part would make the rest of the review worthless, so: the onboarding is the best in the industry. Not "good for telehealth." The best. The app is genuinely well built, and it's the reason so many people who've never used a telehealth service in their lives finish a Hims intake without getting stuck. That's not nothing; most of this market loses people at the health questionnaire.
They're also a publicly traded US company, which means you can read their financials yourself. Nobody is going to run off with your card details. And since their March 2026 settlement with Novo Nordisk, they've moved to real brand-name medication: Wegovy and Zepbound, the actual FDA-approved drugs, not compounded copies from a 503A pharmacy. For anyone who has been nervous about the compounded side of this market, that is a genuine upgrade and it deserves to be said plainly.
Our problem is narrower than any of that. It's the price. More precisely, it's how the price is presented.
The number on the ad is one of two charges
When you land on the Hims weight loss page, you see a figure like $199 a month. That number is real. It just isn't what you pay, because Hims splits your bill in two: there's a membership fee, and there's the medication. They're billed separately, they renew separately, and the advertised price refers to the medication alone.
Here's the full set of line items, as published:
The medication side runs $199 a month for a Wegovy pen, $149 for the oral version, $299 for Zepbound, and shipping is $5. So do the math on the Wegovy pen, the one most people pick. Month one: $39 membership plus $199 medication plus $5 shipping, so $243. That feels reasonable, and it's meant to. Then month two arrives and your membership goes from $39 to $149. Same medication, same shipping, and you're now paying $353 a month.
To be fair to them: Hims is not hiding this. It's on their website, and nothing above is a secret you need an investigation to uncover. But there is a difference between disclosed and obvious, and a two-line bill where the cheaper line is the one in the advertisement is not obvious. We've lost count of the people who quote us the advertised price with no idea there's a membership sitting on top of it.
There is a difference between disclosed and obvious, and the cheaper of the two lines is the one in the ad.
The twelve-month math nobody does at checkout
Monthly prices are the wrong unit for this decision, because GLP-1 treatment isn't a monthly purchase. The clinical data is built around eight to twelve months of continuous use, and stopping early is how people end up back where they started. So the honest number is the annual one. Here it is for all three Hims options, membership and shipping included:
| Hims plan | Month 1 | Month 2 onward | 12-month total |
|---|---|---|---|
| Oral GLP-1 (from $149) | $193 | $303/mo | ~$3,526 |
| Wegovy pen (from $199) | $243 | $353/mo | ~$4,126 |
| Zepbound (from $299) | $343 | $453/mo | ~$5,326 |
Membership ($39 then $149) plus medication plus $5 shipping, at the starting medication price for each format. Prices observed July 2026.
So for the Wegovy pen, the plan whose headline number is $199, the real cost of a full course is somewhere around $4,100. That's the figure to compare against other programs, and it's more than twice the impression the landing page leaves you with.
Set it next to a program that quotes one all-in price and the gap is easier to see than to argue about:
Two things other reviewers get wrong about cancelling
First correction: Hims does not lock you into a prepaid multi-month contract on its standard plan. It's month to month, and you can cancel. There are videos and articles still claiming otherwise, and that information is out of date. Credit where it's due.
What you should be watching instead is the timing. You have to cancel at least 48 hours before your renewal date; miss that window and you're charged for another full cycle. Medication cannot be refunded once it has shipped. And then there's the one that quietly catches the most people:
The cost that isn't on the invoice
There's one more thing the price doesn't cover, and it's medical rather than financial. GLP-1 weight loss has a problem that almost no advertisement mentions: muscle loss. On a standard program, a significant share of the weight you lose isn't fat at all. It's lean muscle mass. You end up lighter on the scale and metabolically worse off than when you started, and that is the single biggest reason people regain everything the moment they come off the medication.
Hims doesn't address this. There's no body composition tracking, so you have no idea what the scale number is actually made of. There's no muscle-preservation protocol. You get the medication and a provider you can message. That's the product, a well-executed one, and for $353 a month it just isn't complete.
What we use instead, held to the same standard
The platform at the top of our ranking right now is Hume Care Plus. Semaglutide is $199 a month; the dual-action plan (tirzepatide plus B12 and glycine) is $299. Critically, that is one single price, with no separate membership stacked on top of it.
Compare like for like: Hims with the Wegovy pen is $353 a month once the intro month expires, against $199 for Hume with semaglutide. Over twelve months that's roughly $4,100 versus about $2,400, so call it $1,700 a year for the same class of treatment.
But the thing that actually moved Hume to number one for us isn't the price, it's what sits inside it: a smart scale shipped to your door for weekly body composition scans, so you know whether you're losing fat or muscle; glycine and B12 built into the protocol specifically to protect lean mass; and clinician access around the clock. It's precisely the layer Hims doesn't have.
And because this review would be worthless if we only applied the fine-print treatment to the company that doesn't pay us, here are three things to know before you sign up with Hume:
- The guarantee on the homepage is not the guarantee in the terms. The homepage suggests you lose 10% of your body weight in six months or get your money back. Section 8A of the actual terms says something narrower: a 90-day window rather than six months, any measurable weight loss rather than 10%, first-time GLP-1 users only, and all thirteen weekly weigh-ins completed with zero missed doses. Miss a single weigh-in and the guarantee is gone. Read 8A yourself before you count on that refund.
- The headline result is company data. The 21.5% average body weight loss over ten months comes from Hume's own internal analysis of 6,846 members. It is not an independent clinical trial, and it should be treated as a company claim.
- They're new. Hume doesn't have years of public reviews behind it the way Hims does, and the current pricing looks like a market-share play: they're buying customers. Good for you if you sign up now; don't assume these prices are permanent.
The situation where Hims wins outright
One important point in Hims' favour before we close. If you have commercial insurance, Hims can run brand-name Wegovy through the Novo Nordisk savings card, and some people are paying between $0 and $25 a month. If that's your situation, everything above about price is irrelevant, so go with Hims. Check your insurance before you pay cash anywhere, at any provider.
And if you're on Medicare, check that before anything else: since July 1, GLP-1 medications are covered at $50 a month for Part D beneficiaries, which beats every cash price on this page. Our GLP-1 insurance coverage guide walks through how to get approved, and our real-cost breakdown covers the same unbundling trick as it shows up on cheaper platforms.
Who Hims & Hers is actually for
- Your insurance or Medicare Part D covers GLP-1, so the cash math stops mattering
- You specifically want brand-name Wegovy or Zepbound, not compounded
- You've bounced off other intakes and want the smoothest possible onboarding
- You want a publicly traded US company whose books you can read
- You're paying cash for a full twelve months
- You want body composition tracking: fat lost versus muscle lost
- You want a muscle-preservation protocol in the plan, not as an afterthought
- You want one price instead of two subscriptions to track and cancel
So here's where we land. Hims is a real company with real medication and a genuinely great app, and if your insurance covers it they're probably your best option in this market. But if you're paying cash for twelve months, you're paying around $1,700 more a year for a program with no body composition tracking and no muscle protection. That's the trade, stated plainly: 7.0 out of 10.
And don't take our word for any of it. Open both pricing pages side by side. Add the membership to the medication. Do the twelve-month arithmetic yourself. If Hims still wins for your situation, go with Hims. We'd genuinely rather you make a good decision than click a link. Our weekly price tracker keeps current pricing on every platform we follow, and the 2026 ranking has the full lineup.
Medical disclaimer: this review covers pricing and service, not medical suitability. GLP-1 therapy is prescription treatment with real side effects, so discuss it with a licensed healthcare provider before starting or stopping. Prices were observed in July 2026 and change frequently; always confirm on the provider's own site before paying.